Cementing the Value of Medical AffairsA number of trends including tougher regulatory controls, increased transparency expectations, an increasingly vocal patient and greater requirements Share XCementing the Value of Medical Affairshttps://pharmaphorum.com/views-analysis-sales-marketing/cementing-value-medical-affairs/
Moving to the next stage in medical affairs: an analysis in melanoma immunotherapyWith an ever-growing array of new scientific data, medical affairs is evolving into its 2.0 iteration. Now, the Share XMoving to the next stage in medical affairs: an analysis in melanoma immunotherapyhttps://pharmaphorum.com/views-and-analysis/moving-next-stage-medical-affairs-analysis-in-melanoma-immunotherapy/
Medical Affairs – the heart of a data-driven, patient-centric pharmaKirk Shepard, Eisai’s SVP of Global Medical Affairs Oncology, talks about how his profession has developed hugely in Share XMedical Affairs – the heart of a data-driven, patient-centric pharmahttps://pharmaphorum.com/views-and-analysis/medical-affairs-heart-data-driven-patient-centric-pharma/
Five questions: How are data and analytics transforming Medical Affairs?How big data and patient centricity are changing the Medical Affairs function. Share XFive questions: How are data and analytics transforming Medical Affairs?https://pharmaphorum.com/views-and-analysis/five-questions-data-analytics-transforming-medical-affairs/